Strong Industry Focus Quartesian operates within the pharmaceutical manufacturing sector with a specialized focus on clinical data services, making it an attractive partner for biopharmaceutical and medical device companies seeking high-quality clinical trial support.

Recent Strategic Acquisition Since its acquisition by Summit Partners in June 2021 and integration into Veranex, Quartesian benefits from increased financial backing and expanded resources, presenting opportunities for collaborative growth and larger-scale project engagements.

Robust Service Portfolio With expertise in statistical programming, data management, and study design, alongside strategic partnerships like the one with Medrio, Quartesian offers comprehensive clinical data solutions that can meet diverse client needs.

Technology-Driven Solutions Utilizing advanced tech stacks such as Amazon Web Services and modern tools like Google Tag Manager, Quartesian delivers scalable, cloud-based data services, opening avenues for selling innovative digital solutions and enhancements.

Market Expansion Potential Operating with a moderate revenue range of $10M to $25M and a team of 201-500 employees, Quartesian offers room for growth through new partnerships, expanded service offerings, and leveraging its recent corporate developments to target larger clients.